HOUSHMAND, MOHAMMAD
 Distribuzione geografica
Continente #
NA - Nord America 381
EU - Europa 204
AS - Asia 96
AF - Africa 6
OC - Oceania 1
Totale 688
Nazione #
US - Stati Uniti d'America 373
IT - Italia 83
IE - Irlanda 41
SG - Singapore 41
SE - Svezia 38
CN - Cina 21
IN - India 9
UA - Ucraina 9
CA - Canada 8
DE - Germania 8
FR - Francia 8
HK - Hong Kong 8
NG - Nigeria 6
VN - Vietnam 6
ID - Indonesia 5
BE - Belgio 3
DK - Danimarca 3
KR - Corea 3
NL - Olanda 3
FI - Finlandia 2
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
GB - Regno Unito 1
HR - Croazia 1
IR - Iran 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 688
Città #
Chandler 100
Dublin 41
Singapore 29
Turin 27
Fairfield 22
Nyköping 21
Ashburn 17
Torino 16
Medford 11
Princeton 10
Woodbridge 10
Tai Wan 8
Wilmington 8
Houston 7
Québec 7
Rome 7
Uppsala 7
Abuja 6
Ann Arbor 6
Cambridge 6
New York 6
Hangzhou 5
Jakarta 5
Novara 5
Seattle 5
Beijing 4
Catania 4
Chennai 4
Hebei 4
Hyderabad 4
Milan 4
San Diego 4
Brussels 3
Capriate San Gervasio 3
Copenhagen 3
Falls Church 3
Santa Clara 3
Seoul 3
Dong Ket 2
Frankfurt am Main 2
Ho Chi Minh City 2
San Mateo 2
Sunnyvale 2
West Jordan 2
Alessandria 1
Alton 1
Amsterdam 1
Bergen 1
Berlin 1
Bratislava 1
Buffalo 1
Cameri 1
Civitavecchia 1
Drakulica Rijeka 1
Duncan 1
Florence 1
Grugliasco 1
Guangzhou 1
Guestrow 1
Guiyang 1
Gunzenhausen 1
Gurgaon 1
Helsinki 1
Jinan 1
Lappeenranta 1
Montreal 1
Nole 1
Olomouc 1
Omaha 1
Paris 1
Redwood City 1
Taipei 1
Vienna 1
Washington 1
Wuhan 1
Xian 1
Totale 482
Nome #
A differentiating and apoptotic therapy for Acute Myeloid Leukaemia using MEDS433, a potent human Dihydroorotate Dehydrogenase inhibitor 103
Nanocarriers as magic bullets in the treatment of leukemia 100
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety 91
A new pro-apoptotic therapy for Acute Myeloid Leukaemia using MEDS433, a potent human Dihydroorotate Dehydrogenase inhibitor 67
The synergism between DHODH inhibitors and dipyridamole leads to metabolic lethality in acute myeloid leukemia 60
The inhibition of human DHODH by M433 leads to differentiation and apoptosis in acute myeloid leukemia 50
Apoptotic and differentiating therapy for AML using potent human dihydroorotate dehydrogenase inhibitor 50
Meds433, a New Dihydroorotate Dehydrogenase Inhibitor, Induces Apoptosis and Differentiation in Acute Myeloid Leukemia 49
Hydroxylated heterocycles as a bioisosteric tool to Modulate the carboxylic function into design potent human Dihydroorotate Dehydrogenase inhibitors 48
Targeting chronic myeloid leukemia stem/progenitor cells using venetoclax-loaded immunoliposome 45
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia 36
Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells 5
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia 1
Totale 705
Categoria #
all - tutte 3.195
article - articoli 0
book - libri 0
conference - conferenze 1.790
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.985


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202175 0 0 2 43 0 0 1 2 0 13 2 12
2021/2022154 4 1 12 4 7 6 3 12 3 32 47 23
2022/2023310 24 37 14 21 19 73 12 24 38 24 12 12
2023/2024114 11 15 7 8 6 21 9 1 3 6 14 13
2024/202552 8 20 11 13 0 0 0 0 0 0 0 0
Totale 705